RVL Pharmaceuticals Plc engages in the development and commercialization of products for neurology and women's health. Its products include Upneeq, Lorzone, and M-72. The company was founded in 1986 and is headquartered in Bridgewater, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of RVL Pharmaceuticals plc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. RVL Pharmaceuticals plc market cap is $111.00.
What is the 52-week high for RVL Pharmaceuticals plc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. RVL Pharmaceuticals plc 52 week high is $0.0002 as of November 20, 2025.
What is the 52-week low for RVL Pharmaceuticals plc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. RVL Pharmaceuticals plc 52 week low is $0.00 as of November 20, 2025.
What is the 50-day moving average of RVL Pharmaceuticals plc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. RVL Pharmaceuticals plc 50-day moving average is $0.00.